secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K/A
Filed at:   2021-08-31T23:59:59+00:00
Accession:  0001607062-21-000309
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma corrects convertible debt date, becomes current on SEC filings, plans to settle notes
--------------------------------------------------------------------------------

- Corrects earlier statement: no convertible debt issued since July 2019, not July 2020.
- Company is no longer delinquent in SEC reporting as of August 27, 2021 10-Q filing.
- Intends to negotiate settlement of remaining convertible notes to reduce or eliminate dilution, no assurance given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000309/0001607062-21-000309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000309/rgbp083121form8ka.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer